2-FMA, or 2-Fluoropentanamine, is a fairly emerging experimental compound gaining notoriety as a potential craving inhibitor and stimulant. Its impacts are thought to be analogous to those of amphetamines, though potentially less intense. However, significant threats are associated with its application, including the possibility of cardiovascular i